thromboxanes has been researched along with Thrombosis in 82 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 47 (57.32) | 18.7374 |
1990's | 8 (9.76) | 18.2507 |
2000's | 8 (9.76) | 29.6817 |
2010's | 15 (18.29) | 24.3611 |
2020's | 4 (4.88) | 2.80 |
Authors | Studies |
---|---|
Böhm, A; Grammbauer, S; Greinacher, A; Hafkemeyer, A; Hasan, M; Jedlitschky, G; Moritz, E; Palankar, R; Rauch, BH; Tolksdorf, C; Tzvetkov, MV; Wolf, R | 1 |
Cheung, SS; Hellsten, Y; Lundberg Slingsby, MH; Nørregaard, LB; Wickham, KA | 1 |
Kim, SD; Kwon, HW; Rhee, MH; Shin, JH | 1 |
Bartimoccia, S; Bufano, M; Cammisotto, V; Carnevale, R; Castellani, V; Ceccarelli, G; Coluccia, A; D'Amati, G; Frati, G; Leopizzi, M; Loffredo, L; Maria Mastroianni, C; Nocella, C; Oliva, A; Pignatelli, P; Pugliese, F; Sciarretta, S; Silvestri, R; Turriziani, O; Venditti, M; Violi, F | 1 |
Aburima, A; Ahmed, Y; Atkinson, L; Calaminus, SDJ; Naseem, KM; Thomas, SG; Yusuf, MZ | 1 |
Badolia, R; Borst, O; Campbell, RA; Kunapuli, SP; Manne, BK; Middleton, E; Münzer, P; Rondina, MT; Walker-Allgaier, B; Weyrich, AS | 1 |
Manne, BK; Rondina, MT | 1 |
Golla, K; Naik, UP; Patel, P | 1 |
Boknäs, N; Faxälv, L; Lindahl, TL; Tunströmer, K | 1 |
Aslan, JE; Badolia, R; Bhavanasi, D; Dangelmaier, C; Eble, JA; Goldfinger, L; Kim, S; Kostyak, J; Kunapuli, S; Merali, S; Patel, A | 1 |
Steg, G | 1 |
Berger, JS; Boone, JL; Jefferies, JL; Jesse, RL; Maisel, AS; McConnell, JP; McCullough, PA; Neath, SX; Wu, AH | 1 |
Frank, S; Guleserian, K; Heistein, L; Journeycake, J; Lemler, M; Mir, A; Wolovitis, J | 1 |
Lindhoff-Last, E; Mani, H | 1 |
Harper, MT; Poole, AW | 1 |
Hu, H; Huang, ZS; Jiang, L; Li, N; Zeng, CL; Zhu, LJ | 1 |
Delgado-Lista, J; Garcia-Rios, A; Lopez-Miranda, J; Perez-Jimenez, F; Perez-Martinez, P | 1 |
Baumgärtel-Allekotte, D; Fischer, J; Heim, Kh; Kaber, G; Kaiser, B; Nagy, N; Nossmann, S; Rauch, B; Schrör, K; Weber, A | 1 |
Davì, G; Sestili, S; Vazzana, N | 1 |
Bhavaraju, K; Bynagari-Settipalli, YS; Jin, J; Kim, S; Kunapuli, SP; Lakhani, P; Rico, MC; Woulfe, D | 1 |
Altman, R; Rouvier, J; Scazziota, A | 1 |
Lecompte, T | 1 |
Gertz, BJ; Reicin, A; Sperling, RS; Weir, MR | 1 |
Fitzgerald, DJ; Maree, AO | 1 |
Bhatt, DL; Meadows, TA | 1 |
Freedman, JE | 1 |
Arnaud, J; Bordet, JC; Bost, M; Chappuis, P; Faure, H; Galan, P; Hercberg, S; Labarère, J; Roussel, AM; Vitoux, D | 1 |
Carey, F; Johnson, M; McMillan, RM | 1 |
Haddeman, E; Hornstra, G; Kloeze, J; Verschuren, PM | 1 |
Salzman, EW; Steer, ML | 1 |
Dyerberg, J; Jørgensen, KA | 1 |
Robinson, DR | 1 |
Verstraete, M | 1 |
Gurewich, V; Louie, S | 1 |
Bunting, S; Moncada, S; Vane, JR | 1 |
Gritsiuk, AI | 1 |
Müller-Beckmann, B; Patscheke, H; Pill, J; Schmidt, FH; Stegmeier, K; Witte, EC; Wolff, HP | 1 |
Chan, CC; Ford-Hutchinson, AW; Hall, RA; Nathaniel, DJ; Yusko, PJ | 1 |
Feinberg, H; Ho, T; Le Breton, GC; Lipowski, JP; Venton, DL; Wu, KK | 1 |
Block, LH; Rhyner, K; Stenger, M | 1 |
Lewis, GP; Smith, JR | 1 |
Leĭtin, VL; Mazurov, AB; Repin, VS | 1 |
Carson, SN; Hunter, GC | 1 |
Bergqvist, D; Björck, CG; Esquivel, CO; Saldeen, P; Saldeen, T | 1 |
Fukumoto, S; Tanaka, K | 1 |
de Boer, AC; Genton, E; Turpie, AG | 1 |
Mitchell, JR | 1 |
Schafer, AI | 1 |
Ally, AI; Horrobin, DF | 1 |
Sun, QW | 1 |
Herman, AG | 1 |
Moncada, S | 1 |
Viinikka, L | 1 |
Hornstra, G | 1 |
Moncada, S; Vane, JR | 2 |
Deutsch, E; Mörz, R | 1 |
Schrör, K | 1 |
Imura, Y; Kato, K; Kawamura, M; Nishikawa, K; Terashita, Z | 1 |
Martin, JF; Smith, RE | 1 |
Alekberova, ZS; Aleksandrova, EN; Kalashnikova, LA; Kubatiev, AA; Mach, ZS; Nasonov, EL; Reshetniak, TM; Rud'ko, IA; Sushkevich, GN | 1 |
Higo, K; Karasawa, A; Shirakura, S; Takeda, M | 1 |
Brunetti, L; Mancuso, S; Marana, R; Margutti, F; Muzii, L; Vacca, M | 1 |
Gerrard, JM; White, JG | 1 |
Malmsten, C | 1 |
Srivastava, KC | 1 |
Okuma, M | 1 |
Gingrich, RD; Hoak, JC | 1 |
Amezcua, JL; Moncada, S | 1 |
McGiff, JC | 1 |
Edmondson, SF; Kovacs, IB; Ratnatunga, CP; Rees, GM | 1 |
Hosoda, Y; Kishida, Y | 1 |
Bekemeier, H; Hirschelmann, R | 1 |
Buja, LM; Campbell, WB; Eidt, J; Golino, P; Willerson, JT | 1 |
Chan, CC; Ford-Hutchinson, A | 1 |
Lane, I; McCollum, C; Meek, A; Poskitt, K | 1 |
Myers, AK; Ramwell, PW | 1 |
Hattori, A | 1 |
Herrmann, KS; Kreuzer, H | 1 |
Rao, GH | 1 |
Broekman, MJ; Gorman, RR; Islam, N; Marcus, AJ; Oglesby, TD; Safier, LB; Ullman, HL; Ward, JW | 1 |
Cazenave, JP; d'Humières, S; Hemmendinger, S; Russo-Marie, F | 1 |
35 review(s) available for thromboxanes and Thrombosis
Article | Year |
---|---|
The current and future landscape of urinary thromboxane testing to evaluate atherothrombotic risk.
Topics: Aspirin; Biomarkers; Blood Platelets; Drug Resistance; Fibrinolytic Agents; Humans; Patient Selection; Platelet Function Tests; Precision Medicine; Predictive Value of Tests; Risk Assessment; Risk Factors; Thrombosis; Thromboxanes; Treatment Outcome; Urinalysis | 2014 |
[Diagnosis, causes, relevance of a complex phenomenon. Resistance to aspirin and clopidogrel].
Topics: Aspirin; Blood Platelets; Clopidogrel; Drug Interactions; Drug Resistance; Humans; Phosphorylation; Platelet Aggregation Inhibitors; Platelet Function Tests; Thrombosis; Thromboxanes; Ticlopidine | 2009 |
Diverse functions of protein kinase C isoforms in platelet activation and thrombus formation.
Topics: Animals; Blood Platelets; Cytoplasmic Granules; Enzyme Activation; Humans; Isoenzymes; Mice; Mice, Knockout; Platelet Activation; Platelet Aggregation; Protein Kinase C; Signal Transduction; Thrombosis; Thromboxanes | 2010 |
Olive oil and haemostasis: platelet function, thrombogenesis and fibrinolysis.
Topics: Animals; Anticoagulants; Dietary Fats; Factor VII; Fatty Acids, Monounsaturated; Fibrinogen; Fibrinolysis; Hemostasis; Humans; Olive Oil; Phenols; Plant Oils; Plasminogen Activator Inhibitor 1; Platelet Activation; Thromboplastin; Thrombosis; Thromboxanes; von Willebrand Factor | 2011 |
Variability in the response to antiplatelet treatment in diabetes mellitus.
Topics: Diabetes Complications; Diabetes Mellitus; Humans; Platelet Aggregation Inhibitors; Thrombosis; Thromboxanes; Treatment Outcome | 2012 |
[Platelet inhibitors: old and new].
Topics: Abciximab; Antibodies, Monoclonal; Arteriosclerosis; Aspirin; Clopidogrel; Coronary Disease; Dipyridamole; Drug Monitoring; Eptifibatide; Humans; Immunoglobulin Fab Fragments; Membrane Proteins; Patient Selection; Peptides; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Receptors, Purinergic P2; Receptors, Purinergic P2Y12; Thrombosis; Thromboxanes; Ticlopidine | 2002 |
Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Topics: Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Blood Pressure; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Epoprostenol; Humans; Isoenzymes; Lactones; Membrane Proteins; Models, Animal; Naproxen; Osteoarthritis; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Randomized Controlled Trials as Topic; Sulfones; Thrombosis; Thromboxanes | 2003 |
Aspirin and coronary artery disease.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Blood Platelets; Clinical Trials as Topic; Coronary Artery Disease; Cyclooxygenase Inhibitors; Drug Resistance; Female; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Models, Biological; Platelet Aggregation; Prostaglandins; Risk Factors; Thrombosis; Thromboxanes | 2004 |
Clinical aspects of platelet inhibitors and thrombus formation.
Topics: Aspirin; Atherosclerosis; Blood Platelets; Cardiovascular Diseases; Cilostazol; Clopidogrel; Dipyridamole; Drug Resistance; Humans; Pentanoic Acids; Platelet Adhesiveness; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2 Receptor Antagonists; Pyridines; Receptor, PAR-1; Stents; Tetrazoles; Thrombosis; Thromboxanes; Ticlopidine | 2007 |
Alternative pathways of arachidonate metabolism: prostaglandins, thromboxane and leukotrienes.
Topics: Animals; Arachidonic Acids; Arteriosclerosis; Blood Platelets; Diabetes Mellitus; Glucocorticoids; Humans; Hypertension; Leukotriene B4; Lipoxygenase; Membrane Lipids; Organ Specificity; Phospholipases; Plants; Prostaglandin-Endoperoxide Synthases; Prostaglandins; SRS-A; Thrombosis; Thromboxanes | 1983 |
Cyclic nucleotides in hemostasis and thrombosis.
Topics: Aspirin; Blood Platelets; Calcium; Cyclic AMP; Cyclic GMP; Diet; Hemostasis; Humans; Male; Phosphorylation; Platelet Aggregation; Prostaglandins; Protein Kinases; Proteins; Thrombosis; Thromboxanes | 1980 |
Marine oils and thrombogenesis.
Topics: Adolescent; Adult; Aged; Animals; Antithrombin III; Arteriosclerosis; Bleeding Time; Blood Vessels; Cats; Child; Dietary Fats; Dogs; Eicosapentaenoic Acid; Epoprostenol; Fatty Acids, Unsaturated; Female; Fibrin; Fish Oils; Humans; Inuit; Lipoproteins; Male; Middle Aged; Platelet Aggregation; Rats; Thrombosis; Thromboxanes | 1982 |
Prostaglandins and anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Central Nervous System Diseases; Cyclic AMP; Drug Hypersensitivity; Female; Gastrointestinal Diseases; Glucocorticoids; Hemostasis; Humans; Kidney; Leukotriene B4; Liver; Mice; Nutrition Disorders; Pregnancy; Prostaglandins; Puerperal Disorders; Thrombosis; Thromboxanes | 1983 |
Introduction: thromboxane in biological systems and the possible impact of its inhibition.
Topics: Animals; Epoprostenol; Humans; Kidney; Neoplasms; Shock; Thrombosis; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes; Vascular Resistance | 1983 |
The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications.
Topics: Animals; Cytochrome P-450 Enzyme System; Diet; Epoprostenol; Hemorrhage; Humans; Intramolecular Oxidoreductases; Platelet Aggregation; Prostaglandin Endoperoxides; Thrombosis; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes | 1983 |
Platelet consumption in cardiovascular disease.
Topics: Angina Pectoris; Animals; Arterial Occlusive Diseases; Arteriosclerosis; Blood Platelets; Cardiovascular Diseases; Cell Survival; Cerebrovascular Disorders; Coronary Disease; Death, Sudden; Heart Valve Diseases; Humans; Myocardial Infarction; Platelet Adhesiveness; Platelet Aggregation; Platelet Function Tests; Rabbits; Radionuclide Imaging; Thromboembolism; Thrombosis; Thromboxanes | 1982 |
Prostaglandins in vascular disease: a seminal approach.
Topics: Arteriosclerosis; Blood Platelets; Blood Vessels; Diabetes Mellitus; Epoprostenol; Forecasting; Humans; Lipids; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxanes; Vascular Diseases | 1981 |
Thromboxane A2 in blood vessel walls and its physiological significance: relevance to thrombosis and hypertension.
Topics: Animals; Blood Vessels; Humans; Hypertension; Thrombosis; Thromboxane A2; Thromboxanes | 1980 |
The role of prostacyclin and thromboxane A2 in the regulation of platelet behaviour.
Topics: Aspirin; Dipyridamole; Epoprostenol; Hemorrhage; Humans; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxane A2; Thromboxanes | 1980 |
Thromboxanes and ischaemic vascular disease.
Topics: Animals; Arteriosclerosis; Epoprostenol; Hemostasis; Humans; Platelet Aggregation; Thrombosis; Thromboxane A2; Thromboxanes | 1982 |
Drugs that modulate prostaglandins, prostacyclin, and thromboxane A2.
Topics: Animals; Cardiovascular Physiological Phenomena; Epoprostenol; Fatty Acids; Fibrinolytic Agents; Hemostasis; Humans; Prostaglandins; Thrombosis; Thromboxane A2; Thromboxanes | 1982 |
Antiplatelet drugs. A comparative review.
Topics: Adenosine Diphosphate; Animals; Aspirin; Base Sequence; Blood Platelets; Consensus Sequence; Humans; Molecular Sequence Data; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIb-IX Complex; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Thrombin; Thrombosis; Thromboxanes | 1995 |
Endogenous mediators and thrombophilia.
Topics: Animals; Blood Platelets; Cell Size; Endothelins; Endothelium, Vascular; Epoprostenol; Homeostasis; Humans; Megakaryocytes; Nitric Oxide; Platelet Activation; Thrombosis; Thromboxanes | 1994 |
Prostaglandins and thromboxanes: "middlemen" modulating platelet function in hemostasis and thrombosis.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Arteriosclerosis; Blood Coagulation; Blood Platelets; Calcium; Cyclic AMP; Hemostasis; Humans; Prostaglandins; Prostaglandins G; Prostaglandins H; Rats; Thrombosis; Thromboxane A2; Thromboxanes | 1978 |
Prostaglandins, thromboxanes and platelets.
Topics: Arachidonic Acids; Blood Platelet Disorders; Blood Platelets; Cyclic AMP; Hemostasis; Humans; In Vitro Techniques; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandins; Thrombosis; Thromboxanes | 1979 |
[Determination of TXA2 formed by blood platelets and PGX formed by blood vessels and formation of thrombi].
Topics: Blood Platelets; Blood Vessels; Epoprostenol; Humans; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxane A2; Thromboxanes | 1977 |
Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis.
Topics: Arachidonic Acids; Aspirin; Epoprostenol; Hemostasis; Humans; Peroxides; Platelet Adhesiveness; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandins; Thrombosis; Thromboxanes; Vasodilator Agents | 1978 |
[Thromboxane A2 antagonist, prostacyclin (PGI2)--its in vivo secretion and action mechanism].
Topics: Animals; Epoprostenol; Humans; Intracranial Arteriosclerosis; Microsomes; Platelet Aggregation; Prostaglandins; Rabbits; Rats; Thrombosis; Thromboxane A2; Thromboxanes | 1978 |
Platelet-endothelial cell interactions.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Complement System Proteins; Endothelium; Epoprostenol; Factor VIII; Granulocytes; Hemostasis; Humans; Platelet Adhesiveness; Platelet Aggregation; Thrombin; Thrombosis; Thromboxanes | 1979 |
Prostaglandins in circulatory disorders.
Topics: Angiotensin II; Antihypertensive Agents; Arachidonic Acids; Arteriosclerosis; Aspirin; Blood Platelets; Diet; Dipyridamole; Eicosanoic Acids; Humans; Hypertension; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxanes; Vascular Diseases | 1979 |
[Pulmonary vascular changes in the collagen vascular diseases].
Topics: Collagen Diseases; Humans; Lupus Coagulation Inhibitor; Prostaglandins; Pulmonary Artery; Pulmonary Veins; Thrombosis; Thromboxanes | 1991 |
Specific platelet mediators and unstable coronary artery lesions. Experimental evidence and potential clinical implications.
Topics: Angina Pectoris; Animals; Biomechanical Phenomena; Blood Platelets; Coronary Circulation; Coronary Disease; Coronary Vessels; Humans; Muscle Tonus; Platelet Aggregation; Thrombosis; Thromboxanes | 1989 |
Thromboxane in sudden death.
Topics: Angina Pectoris; Animals; Arachidonic Acid; Arachidonic Acids; Calcium Channel Blockers; Castration; Death; Estrogens; Fatty Acids, Monounsaturated; Fatty Acids, Unsaturated; Female; Glucocorticoids; Humans; Male; Methacrylates; Prostaglandin Endoperoxides, Synthetic; Sex Factors; Testosterone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxanes | 1985 |
[Hypothetical theory of thromboxane and prostacycline balance in hemostasis and thrombosis].
Topics: Animals; Epoprostenol; Hemostasis; Humans; Platelet Aggregation Inhibitors; Thrombosis; Thromboxanes | 1987 |
Inhibition of platelet function in thrombosis.
Topics: Arachidonic Acids; Aspirin; Blood Platelets; Chromatography, Gas; Depression, Chemical; Eicosanoic Acids; Female; Humans; Male; Microcirculation; Neutrophils; Thrombosis; Thromboxanes; Tritium | 1985 |
2 trial(s) available for thromboxanes and Thrombosis
Article | Year |
---|---|
Effect of low dose antioxidant vitamin and trace element supplementation on the urinary concentrations of thromboxane and prostacyclin metabolites.
Topics: 6-Ketoprostaglandin F1 alpha; Antioxidants; Arteriosclerosis; beta Carotene; Biomarkers; Dietary Supplements; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Compliance; Platelet Activation; Prostaglandins I; Selenium; Thrombosis; Thromboxane B2; Thromboxanes; Trace Elements; Vitamins; Zinc | 2007 |
A comparison of the effects of a thromboxane antagonist and cyclo-oxygenase inhibitor on platelet accumulation in arterial grafts.
Topics: Aorta; Aspirin; Biphenyl Compounds; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Femoral Artery; Humans; Thrombosis; Thromboxanes; Vascular Surgical Procedures | 1987 |
45 other study(ies) available for thromboxanes and Thrombosis
Article | Year |
---|---|
Specific inhibition of the transporter MRP4/ABCC4 affects multiple signaling pathways and thrombus formation in human platelets.
Topics: Adenosine Diphosphate; ATP-Binding Cassette Transporters; Blood Platelets; Calcium; Fluorescein-5-isothiocyanate; Humans; Integrins; Multidrug Resistance-Associated Proteins; Nucleotides, Cyclic; Signal Transduction; Thrombosis; Thromboxanes | 2022 |
High-Intensity Exercise Training Improves Basal Platelet Prostacyclin Sensitivity and Potentiates the Response to Dual Anti-Platelet Therapy in Postmenopausal Women.
Topics: Adenosine; Adenosine Diphosphate; Aspirin; Cyclooxygenase 1; Diphosphates; Dual Anti-Platelet Therapy; Epoprostenol; Estrogens; Exercise; Female; Humans; Nitric Oxide; Peptides; Platelet Aggregation Inhibitors; Postmenopause; Receptors, Epoprostenol; Receptors, Thromboxane; Thrombin; Thrombosis; Thromboxanes | 2022 |
Pharmacological Actions of 5-Hydroxyindolin-2 on Modulation of Platelet Functions and Thrombus Formation via Thromboxane A
Topics: Blood Platelets; Humans; Phosphatidylinositol 3-Kinases; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Thromboxanes | 2022 |
Toll-Like Receptor 4-Dependent Platelet-Related Thrombosis in SARS-CoV-2 Infection.
Topics: Antibodies, Monoclonal; Blood Platelets; COVID-19; Cross-Sectional Studies; Humans; SARS-CoV-2; Thrombosis; Thromboxanes; Toll-Like Receptor 4 | 2023 |
Reversal of stress fibre formation by Nitric Oxide mediated RhoA inhibition leads to reduction in the height of preformed thrombi.
Topics: Actin Cytoskeleton; Blood Platelets; Cytoskeleton; Healthy Volunteers; Humans; Nitric Oxide; Phosphorylation; Platelet Activation; Platelet Aggregation Inhibitors; rhoA GTP-Binding Protein; Shear Strength; Stress Fibers; Thrombosis; Thromboxanes | 2018 |
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway.
Topics: 3-Phosphoinositide-Dependent Protein Kinases; Animals; Blood Platelets; Disease Models, Animal; Humans; Mice, Knockout; Mitogen-Activated Protein Kinases; Phosphorylation; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Mas; Proto-Oncogene Proteins c-raf; Pulmonary Embolism; Pyrimidines; Signal Transduction; Thiophenes; Thrombosis; Thromboxanes | 2018 |
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway: reply.
Topics: Blood Platelets; Humans; Protein Serine-Threonine Kinases; Thrombosis; Thromboxanes | 2018 |
PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway: comment.
Topics: Blood Platelets; Humans; Protein Serine-Threonine Kinases; Thrombosis; Thromboxanes | 2018 |
Quantification of Platelet Contractile Movements during Thrombus Formation.
Topics: Blood Platelets; Cell Movement; Cells, Cultured; Computer Simulation; Diffusion Chambers, Culture; Humans; Microscopy, Fluorescence; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Purinergic P2Y12; Signal Transduction; Thrombosis; Thromboxanes; Time-Lapse Imaging | 2018 |
ELMO1 deficiency enhances platelet function.
Topics: Adaptor Proteins, Signal Transducing; Animals; Blood Platelets; Gene Deletion; Hemostasis; Humans; Mice; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombosis; Thromboxanes | 2019 |
[Antiplatelet agents].
Topics: Atherosclerosis; Humans; Phosphodiesterase Inhibitors; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Pyridines; Receptors, Thrombin; Thrombosis; Thromboxanes | 2013 |
Aspirin Resistance in Single-Ventricle Physiology: Aspirin Prophylaxis Is Not Adequate to Inhibit Platelets in the Immediate Postoperative Period.
Topics: Aspirin; Blalock-Taussig Procedure; Dose-Response Relationship, Drug; Drug Resistance; Female; Follow-Up Studies; Humans; Hypoplastic Left Heart Syndrome; Incidence; Infant; Infant, Newborn; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Texas; Thrombelastography; Thrombosis; Thromboxanes | 2015 |
Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase.
Topics: Adenosine Diphosphate; Adult; Animals; Arteries; Caffeic Acids; Collagen; Dose-Response Relationship, Drug; Female; Flow Cytometry; Humans; Lactates; Male; Mice; Phosphoinositide-3 Kinase Inhibitors; Platelet Activation; Platelet Aggregation; Signal Transduction; Thrombin; Thrombosis; Thromboxanes | 2010 |
Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit.
Topics: Animal Feed; Animals; Aorta; Aspirin; Atherosclerosis; Cholesterol; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Drug Antagonism; Epoprostenol; Female; Fibrinolytic Agents; Immunohistochemistry; Lactones; Male; Platelet Aggregation Inhibitors; Rabbits; Sulfones; Thrombosis; Thromboxanes | 2011 |
Protein kinase C isoform ε negatively regulates ADP-induced calcium mobilization and thromboxane generation in platelets.
Topics: Adenosine Diphosphate; Animals; Blood Platelets; Calcium; Disease Models, Animal; Humans; Intracellular Fluid; Mice; Platelet Aggregation; Platelet Count; Protein Kinase C-epsilon; Signal Transduction; Thrombosis; Thromboxanes | 2012 |
Aspirin resistance.
Topics: Aspirin; Biomarkers; Cyclooxygenase Inhibitors; Drug Resistance; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Predictive Value of Tests; Risk; Thrombosis; Thromboxane B2; Thromboxanes | 2002 |
Heritability, platelet function, and aspirin: a link established but cause unknown.
Topics: Arachidonic Acid; Aspirin; Black or African American; Blood Platelets; Cardiovascular Diseases; Cyclooxygenase 1; Female; Genetic Heterogeneity; Genetic Predisposition to Disease; Genetic Variation; Humans; Male; Membrane Proteins; Phenotype; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Sex Characteristics; Thrombophilia; Thrombosis; Thromboxanes; White People | 2007 |
Dietary-fat-induced changes in the formation of prostanoids of the 2 and 3 series in relation to arterial thrombosis (rat) and atherosclerosis (rabbit).
Topics: Animals; Arteriosclerosis; Blood Platelets; Diet, Atherogenic; Dietary Fats; Disease Models, Animal; Epoprostenol; Fatty Acids; Liver; Phospholipids; Prostaglandins; Rabbits; Rats; Thrombosis; Thromboxane B2; Thromboxanes | 1983 |
The antithrombotic effect of aspirin and dipyridamole in relation to prostaglandin synthesis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Dipyridamole; Epoprostenol; Fibrinolytic Agents; Male; Prostaglandins; Rabbits; Thrombosis; Thromboxanes | 1983 |
[Problems of intravascular blood coagulation and thrombus formation in ischemic heart disease].
Topics: Blood Coagulation; Coronary Disease; Disseminated Intravascular Coagulation; Epoprostenol; Humans; Myocardial Infarction; Platelet Aggregation; Thrombosis; Thromboxanes | 1984 |
The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drug.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Epoprostenol; Female; Fibrinolytic Agents; Guinea Pigs; Male; Muscle Contraction; Muscle, Smooth, Vascular; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Rabbits; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
Inhibition of prostanoid-mediated platelet aggregation in vivo and in vitro by 3-hydroxymethyl-dibenzo(b,f)thiepin 5,5-dioxide (L-640,035).
Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Arachidonic Acids; Collagen; Dibenzothiepins; Electric Stimulation; Female; Guinea Pigs; Humans; Male; Platelet Aggregation; Prostaglandin Endoperoxides, Synthetic; Rabbits; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxanes | 1984 |
Antagonism of thromboxane A2/prostaglandin H2 by 13-azaprostanoic acid prevents platelet deposition to the de-endothelialized rabbit aorta in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Fatty Acids; Male; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandins H; Prostanoic Acids; Rabbits; Thrombosis; Thromboxane A2; Thromboxanes | 1984 |
[Divergence between the pharmacologic and clinical effects of inhibitors of prostaglandin synthesis].
Topics: Aspirin; Blood Platelets; Dipyridamole; Drug Interactions; Epoprostenol; Humans; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandin-Endoperoxide Synthases; Salicylates; Salicylic Acid; Sulfinpyrazone; Thrombosis; Thromboxanes | 1984 |
Prostaglandin endoperoxides and thromboxane A2 in thrombus formation in the hamster cheek pouch in vivo.
Topics: Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Cheek; Cricetinae; Cyclooxygenase Inhibitors; Dipyridamole; Epoprostenol; Male; Mesocricetus; Microscopy, Electron; Platelet Aggregation; Sulfinpyrazone; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1984 |
[Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Arachidonic Acids; Aspirin; Blood Platelets; Collagen; Humans; Microscopy, Electron, Scanning; Platelet Aggregation; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Thrombosis; Thromboxane A2; Thromboxanes | 1984 |
Arterial wall thromboxane: dominance after surgery predisposes to thrombosis.
Topics: Animals; Blood Vessel Prosthesis; Carotid Arteries; Graft Occlusion, Vascular; Ibuprofen; Sheep; Thrombosis; Thromboxane A2; Thromboxanes | 1984 |
Thromboxane production in umbilical vein grafts.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Female; Humans; Male; Sheep; Thrombosis; Thromboxane B2; Thromboxanes; Umbilical Veins | 1984 |
Protective effects of thromboxane A2 synthetase inhibitors on endotoxin shock.
Topics: Animals; Fibrinogen; Glucuronidase; Kidney; Male; Methacrylates; Oxidoreductases; Platelet Count; Rats; Rats, Inbred Strains; Shock, Septic; Thrombosis; Thromboxane A2; Thromboxane B2; Thromboxane-A Synthase; Thromboxanes | 1983 |
Deficiency of platelet lipoxygenase activity in myeloproliferative disorders.
Topics: Blood Platelets; Hemorrhage; Hemostasis; Humans; Lipoxygenase; Myeloproliferative Disorders; Oxygen Consumption; Thromboembolism; Thrombosis; Thromboxanes | 1982 |
[Function of prostaglandins in platelet aggregation].
Topics: Animals; Epoprostenol; Fibrinolytic Agents; Platelet Aggregation; Prostaglandins; Rabbits; Rats; Thrombosis; Thromboxane A2; Thromboxanes | 1980 |
[The role of prostacycline, thromboxane A2 and prostaglandins in platelet aggregation (author's transl)].
Topics: Arteriosclerosis; Aspirin; Epoprostenol; Hemostasis; Platelet Aggregation; Prostaglandin Antagonists; Prostaglandins; Thrombosis; Thromboxane A2; Thromboxanes | 1981 |
[Prostacyclin and thromboxane in thrombosing atherosclerotic diseases].
Topics: Arteriosclerosis; Epoprostenol; Humans; Prostaglandins; Thrombosis; Thromboxane A2; Thromboxanes | 1981 |
[Action of tioxaprofen on platelet function (author's transl)].
Topics: Adenosine Diphosphate; Alkaline Phosphatase; Anti-Inflammatory Agents; Blood Platelets; Blood Urea Nitrogen; Creatinine; Humans; In Vitro Techniques; Malondialdehyde; Platelet Aggregation; Propionates; Thrombosis; Thromboxanes | 1982 |
Effects of thromboxane A2 synthase inhibitors (CV-4151 and ozagrel), aspirin, and ticlopidine on the thrombosis caused by endothelial cell injury.
Topics: Animals; Aspirin; Bleeding Time; Endothelium, Vascular; Fatty Acids, Monounsaturated; Femoral Vein; Male; Methacrylates; Platelet Aggregation; Pyridines; Rats; Rats, Sprague-Dawley; Thrombosis; Thromboxane-A Synthase; Thromboxanes; Ticlopidine | 1995 |
[Levels of thromboxane and prostacyclin in patients with systemic lupus erythematosus and antiphospholipid syndrome].
Topics: Adult; Antiphospholipid Syndrome; Epoprostenol; Female; Humans; Lupus Erythematosus, Systemic; Male; Pregnancy; Pregnancy Complications; Risk Factors; Syndrome; Thrombocytopenia; Thrombosis; Thromboxanes | 1994 |
Antithrombotic effects of KW-3635, a thromboxane A2-receptor antagonist, in guinea pigs.
Topics: Animals; Arterial Occlusive Diseases; Aspirin; Benzimidazoles; Benzoxepins; Blood Coagulation; Blood Platelets; Disease Models, Animal; Erythrocyte Count; Femoral Artery; Guinea Pigs; Lauric Acids; Male; Phenylacetates; Platelet Count; Sulfonamides; Thrombosis; Thromboxane A2; Thromboxanes; Ticlopidine | 1994 |
Postoperative adhesion prevention with low-dose aspirin: effect through the selective inhibition of thromboxane production.
Topics: Abdominal Muscles; Animals; Aspirin; Female; Ovary; Platelet Aggregation Inhibitors; Postoperative Complications; Rabbits; Thrombosis; Thromboxanes; Uterus | 1998 |
Prostacyclin, thromboxane A2 interactions in haemostasis and thrombosis.
Topics: Animals; Aspirin; Blood Platelets; Dose-Response Relationship, Drug; Epoprostenol; Humans; Platelet Aggregation; Prostaglandins; Thrombosis; Thromboxane A2; Thromboxanes | 1979 |
High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation.
Topics: Aspirin; Coronary Artery Bypass; Dose-Response Relationship, Drug; Female; Hemostasis; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Complications; Thrombin; Thrombosis; Thromboxanes | 1992 |
Role of eicosanoids in the kappa-carrageenin rat tail thrombosis.
Topics: Aminopyrine; Animals; Aspirin; Benzydamine; Cardiovascular Agents; Carrageenan; Diclofenac; Epoprostenol; Female; Iloprost; Imidazoles; Phenylbutazone; Rats; Rats, Inbred Strains; Thrombosis; Thromboxanes; Trapidil | 1988 |
Potentiation of the inhibitory effect of a thromboxane A2 antagonist (L-640,035) on arterial thrombosis formation in rabbit by the angiotensin converting enzyme inhibitor enalapril.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin-Converting Enzyme Inhibitors; Animals; Dibenzothiepins; Dipeptides; Drug Synergism; Enalapril; Female; Hexamethonium Compounds; Hydralazine; Male; Prostaglandin Antagonists; Rabbits; Radioimmunoassay; Thrombosis; Thromboxane A2; Thromboxanes | 1985 |
Local measurements of thrombus induced vasoconstriction in vivo.
Topics: Animals; Blood Pressure; Cricetinae; Mesocricetus; Microcirculation; Papaverine; Phentolamine; Prostaglandins, Synthetic; Thrombosis; Thromboxanes; Vasoconstriction | 1988 |
Influence of anti-platelet drugs on platelet-vessel wall interactions.
Topics: Aspirin; Calcium Channel Blockers; Endothelium, Vascular; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Thromboxanes | 1987 |
[Physiology of the interactions of blood and the blood vessel wall. Role of pharmacologically active lipids].
Topics: Arachidonic Acids; Blood Platelets; Blood Vessels; Cell Membrane; Endothelium; Humans; Leukocytes; Microscopy, Electron, Scanning; Muscle, Smooth, Vascular; Phospholipids; Platelet Activating Factor; Prostaglandins; SRS-A; Thrombosis; Thromboxanes | 1985 |